18.42 EUR
-0.31 (-1.65%)
- Market cap
- EUR 1284m
- Volume
- 412,870
- Listing
- Euronext Amsterdam
Investor Relations
Thanatos Laboratories is a clinical-stage biopharmaceutical company developing treatments for rare neurodegenerative disease. This section contains regulated information, financial reporting and governance disclosures.
Media and analysts
Accredited journalists and sell-side analysts can access release material and conference call details through the media centre.
Accreditation is arranged by Investor Relations. Request access.